First clinical data demonstrating robust confirmed responses and CNS anti-tumor activity for firmonertinib in first-line NSCLC EGFR PACC mutations Global pivotal Phase 3 monotherapy study for ...

Lung cancer remains the preeminent cancer in terms of mortality globally, primarily due to late-stage detection in many patients. Despite advancements in ...

Immune checkpoint inhibitors (ICPis) have revolutionized the therapeutic landscape of lung cancer with unprecedented survival results in most of the ...

A cancer patient and amputee is furious after being denied a Blue Badge – despite having her toe removed and suffering with ...

AI’s deployment in medical diagnosis often takes two distinct forms: as a tool that assists professionals in real-time ...

Gunnar Boysen, an associate professor of environmental and occupational health at UAMS, will discuss his work studying tumor metabolism and using advanced therapy approaches this Wednesday.

More than a decade after Merck’s Keytruda and BMS’ Yervoy ushered in the immuno-oncology revolution, the space is at a ...

Higher dietary and blood lycopene levels are linked to a reduced risk of cancer, with the strongest protective effects seen ...

Over 500 people took on the challenge of climbing Key Tower's 54 flights of stairs Sunday for the 15th annual Fight for Air ...

The first patient with small cell lung cancer has been dosed in a trial of peluntamig (PT217) combined with chemotherapy.

Nearly half a million people in Kansas, and over one million in Missouri, live with lung disease. And on Sunday morning, ...

Utah has the lowest rate of smoking in the nation, but lung cancer is the leading cause of cancer death in the state, ...